Global pharmaceutical giant Eli Lilly & Co. is considering a $5.9 billion plant in northeast Houston, a potential economic ...

There are many problems with the plan. For instance, it ignores the fact that generic drugs, which make up 90% of ...

For pharma, an industry in which gross margins are among the highest ... Companies responded by setting up complex offshore structures to house intellectual property and book profits in low-tax ...

whose bottom lines depend on anticompetitive business models. There is no way to lower drug costs for American patients without costing Big Pharma, whose executives can afford patio dinners at Mar ...

The authors cite three areas where big pharma want to concentrate: on the prescription pharmaceutical business, on innovative products, and on fewer targeted therapeutic areas. The overall ...

Europe’s pharma ... business leaders and their companies. But the “America first” protectionist approach favoured by the current administration in Washington will pass. And when it does Big ...